Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Metcalfe

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Hereditary Cancer in Clinical Practice|May 14, 2024
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutationsSteven A Narod, Kelly Metcalfe, Amy Finch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel, Mark Robson, Barbara Pasini, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer PreventionLauren C Tindale, Almira Zhantuyakova, Stephanie Lam, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Gynecologic Oncology|August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variantAdriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A ReappraisalJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Hereditary Cancer in Clinical Practice|May 14, 2024
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutationsSteven A Narod, Kelly Metcalfe, Amy Finch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2005
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel, Mark Robson, Barbara Pasini, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer PreventionLauren C Tindale, Almira Zhantuyakova, Stephanie Lam, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Gynecologic Oncology|August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variantAdriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: A ReappraisalJoanne Kotsopoulos, Jan Lubinski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|December 17, 2025
Menopausal hormone therapy and the risk of breast cancer in women with a pathogenic variant in BRCA1 or BRCA2Joanne Kotsopoulos, Marta Seca, Jacek Gronwald, et al.
Pageof 8